News Center - Luye Life Sciences

News Center

Luye Pharma Announces 2024 Half Year Results

2024-08-29 MORE>
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases ...

2024-08-28 MORE>
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® for Treating Schizophrenia and Schizoa...

2024-07-30 MORE>
Luye Pharma’s Analgesic Drug Mimeixin (Oxycodone Hydrochloride and Naloxone Hydrochloride...

2024-07-04 MORE>
Luye Pharma’s Jinyouping (Rotigotine Microspheres for Injection) Approved for Marketing ...

2024-06-21 MORE>
Luye Pharma's Meibirui (Paliperidone Palmitate Injection) Approved for Marketing in China...

2024-06-12 MORE>

Total:138 / Page:23 First Prev 1 2 3 4 5 Next Last

鲁ICP备05023892号-5 LUYE All Rights Reserved Privacy policy Terms of use

TOP